- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 152052, 13 pages
Glutamine and Alanyl-Glutamine Increase RhoA Expression and Reduce Clostridium difficile Toxin-A-Induced Intestinal Epithelial Cell Damage
1Department of Morphology, Faculty of Medicine, Federal University of Ceará, Delmiro de Farias, 60416-030 Fortaleza, CE, Brazil
2Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, 1127 Coronel Nunes de Melo, 60430-270 Fortaleza, CE, Brazil
3Department of Physics, Faculty of Physics, Federal University of Ceará, 922 Campus do Pici, 60455-760 Fortaleza, CE, Brazil
4Biomedical Sciences Institute, Federal University of Rio de Janeiro, 373 Avenue Carlos Chagas, 21941-902 Rio de Janeiro, RJ, Brazil
5Division of Infectious Diseases and International Health, Center for Global Health, University of Virginia, 345 Crispell Drive, Room 2709, Charlottesville, VA 22903, USA
Received 22 August 2012; Accepted 12 November 2012
Academic Editor: Reinaldo B. Oriá
Copyright © 2013 Ana A. Q. A. Santos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. N. Ananthakrishnan, M. Issa, and D. G. Binion, “Clostridium difficile and inflammatory bowel disease,” Medical Clinics of North America, vol. 94, no. 1, pp. 135–153, 2010.
- D. B. Blossom and L. C. McDonald, “The challenges posed by reemerging Clostridium difficile infection,” Clinical Infectious Diseases, vol. 45, no. 2, pp. 222–227, 2007.
- R. Gaynes, D. Rimland, E. Killum et al., “Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use,” Clinical Infectious Diseases, vol. 38, no. 5, pp. 640–645, 2004.
- C. A. Muto, M. Pokrywka, K. Shutt et al., “A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use,” Infection Control and Hospital Epidemiology, vol. 26, no. 3, pp. 273–280, 2005.
- L. C. McDonald, M. Owings, and D. B. Jernigan, “Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003,” Emerging Infectious Diseases, vol. 12, no. 3, pp. 409–415, 2006.
- J. Pépin, N. Saheb, M. A. Coulombe et al., “Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec,” Clinical Infectious Diseases, vol. 41, no. 9, pp. 1254–1260, 2005.
- C. P. Kelly, “A 76-year-old man with recurrent Clostridium difficile associated diarrhea: review of C difficile infection,” Journal of the American Medical Association, vol. 301, no. 9, pp. 954–962, 2009.
- V. G. Loo, L. Poirier, M. A. Miller, et al., “A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality,” The New England Journal of Medicine, vol. 353, no. 23, pp. 2442–2449, 2005.
- L. C. McDonald, G. E. Killgore, A. Thompson et al., “An epidemic, toxin gene-variant strain of Clostridium difficile,” The New England Journal of Medicine, vol. 353, no. 23, pp. 2433–2441, 2005.
- J. Pépin, L. Valiquette, M. E. Alary et al., “Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity,” Canadian Medical Association Journal, vol. 171, no. 5, pp. 466–472, 2004.
- J. Freeman, M. P. Bauer, S. D. Baines et al., “The changing epidemiology of Clostridium difficile infections,” Clinical Microbiology Reviews, vol. 23, no. 3, pp. 529–549, 2010.
- T. McGuire, P. Dobesh, D. Klepser, M. Rupp, and K. Olsen, “Clinically important interaction between statin drugs and Clostridium difficile toxin?” Medical Hypotheses, vol. 73, no. 6, pp. 1045–1047, 2009.
- I. Castagliuolo, C. P. Kelly, B. S. Qiu, S. T. Nikulasson, J. Thomas LaMont, and C. Pothoulakis, “IL-11 inhibits Clostridium difficile toxin A enterotoxicity in rat ileum,” American Journal of Physiology, vol. 273, no. 2, pp. G333–G341, 1997.
- M. Riegler, R. Sedivy, C. Pothoulakis et al., “Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro,” Journal of Clinical Investigation, vol. 95, no. 5, pp. 2004–2011, 1995.
- D. Drudy, S. Fanning, and L. Kyne, “Toxin A-negative, toxin B-positive Clostridium difficile,” International Journal of Infectious Diseases, vol. 11, no. 1, pp. 5–10, 2007.
- H. Genth, S. C. Dreger, J. Huelsenbeck, and I. Just, “Clostridium difficile toxins: more than mere inhibitors of Rho proteins,” The International Journal of Biochemistry and Cell Biology, vol. 40, no. 4, pp. 592–597, 2008.
- H. Kim, S. H. Rhee, C. Pothoulakis, and J. T. LaMont, “Clostridium difficile toxin A binds colonocyte Src causing dephosphorylation of focal adhesion kinase and paxillin,” Experimental Cell Research, vol. 315, no. 19, pp. 3336–3344, 2009.
- M. Sauerborn, P. Leukel, and C. von Eichel-Streiber, “The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells arid prevents mouse lethality,” FEMS Microbiology Letters, vol. 155, no. 1, pp. 45–54, 1997.
- H. J. Nam, J. K. Kang, S. K. Kim et al., “Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation,” Journal of Biological Chemistry, vol. 285, no. 43, pp. 32888–32896, 2010.
- G. A. C. Brito, M. H. L. P. Souza, A. A. Melo-Filho et al., “Role of pertussis toxin A subunit in neutrophil migration and vascular permeability,” Infection and Immunity, vol. 65, no. 3, pp. 1114–1118, 1997.
- K. Weiss, “Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer,” International Journal of Antimicrobial Agents, vol. 33, no. 1, pp. 4–7, 2009.
- G. A. C. Brito, J. Fujji, B. A. Carneiro-Filho, A. A. M. Lima, T. Obrig, and R. L. Guerrant, “Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells,” The Journal of Infectious Diseases, vol. 186, no. 10, pp. 1438–1447, 2002.
- G. A. C. Brito, B. Carneiro-Filho, R. B. Oriá, R. V. Destura, A. A. M. Lima, and R. L. Guerrant, “Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage: role of Gln and Ala-Gln in toxin A effects,” Digestive Diseases and Sciences, vol. 50, no. 7, pp. 1271–1278, 2005.
- M. B. Braga-Neto, C. A. Warren, R. B. Oriá et al., “Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro,” Digestive Diseases and Sciences, vol. 53, no. 10, pp. 2687–2696, 2008.
- G. A. C. Brito, G. W. Sullivan, W. P. Ciesla Jr., H. T. Carper, G. L. Mandell, and R. L. Guerrant, “Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function,” The Journal of Infectious Diseases, vol. 185, no. 9, pp. 1297–1306, 2002.
- B. A. Carneiro, J. Fujii, G. A. C. Brito et al., “Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro,” Infection and Immunity, vol. 74, no. 1, pp. 81–87, 2006.
- B. A. Carneiro-Filho, R. B. Oriá, K. Wood Rea et al., “Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice,” Nutrition, vol. 20, no. 10, pp. 934–941, 2004.
- G. P. Oliveira, C. M. Dias, P. Pelosi, and P. R. M. Rocco, “Understanding the mechanisms of glutamine action in critically ill patients,” Anais da Academia Brasileira de Ciencias, vol. 82, no. 2, pp. 417–430, 2010.
- K. D. Jandt, “Developments and perspectives of scanning probe microscopy (SPM) on organic materials systems,” Materials Science and Engineering R, vol. 21, no. 5-6, pp. 221–295, 1998.
- C. S. Quirino, G. O. Leite, L. M. Rebelo, et al., “Healing potential of Pequi (Caryocar coriaceum Wittm.) fruit pulp oil,” Phytochemistry Letters, vol. 2, no. 4, pp. 179–183, 2009.
- C. Heneweer, M. Schmidt, H. W. Denker, and M. Thie, “Molecular mechanisms in uterine epithelium during trophoblast binding: the role of small GTPase RhoA in human uterine Ishikawa cells,” Journal of Experimental and Clinical Assisted Reproduction, vol. 2, no. 4, pp. 1–11, 2005.
- C. Schwan, B. Stecher, T. Tzivelekidis et al., “Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria,” PLoS Pathogens, vol. 5, no. 10, Article ID e1000626, 2009.
- A. C. B. Possidonio, M. L. Senna, D. M. Portilho et al., “α-cyclodextrin enhances myoblast fusion and muscle differentiation by the release of IL-4,” Cytokine, vol. 55, no. 2, pp. 280–287, 2011.
- J. Gerdes, H. Lemke, and H. Baisch, “Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67,” Journal of Immunology, vol. 133, no. 4, pp. 1710–1715, 1984.
- D. Docheva, D. Padula, C. Popov, W. Mutschler, H. Clausen-Schaumann, and M. Schieker, “Researching into the cellular shape, volume and elasticity of mesenchymal stem cells, osteoblasts and osteosarcoma cells by atomic force microscopy: stem cells,” Journal of Cellular and Molecular Medicine, vol. 12, no. 2, pp. 537–552, 2008.
- H. Kim, E. Kokkotou, X. Na et al., “Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase,” Gastroenterology, vol. 129, no. 6, pp. 1875–1888, 2005.
- H. Kim, S. H. Rhee, C. Pothoulakis, and J. T. LaMont, “Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of fas ligand,” Gastroenterology, vol. 133, no. 3, pp. 875–886, 2007.
- I. Just, M. Wilm, J. Selzer et al., “The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins,” Journal of Biological Chemistry, vol. 270, no. 23, pp. 13932–13936, 1995.
- I. Castagliuolo, M. Riegler, A. Pasha et al., “Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis,” Journal of Clinical Investigation, vol. 101, no. 8, pp. 1547–1550, 1998.
- N. Fernandez, Q. Chang, D. W. Buster, D. J. Sharp, and A. Ma, “A model for the regulatory network controlling the dynamics of kinetochore microtubule plus-ends and poleward flux in metaphase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 19, pp. 7846–7851, 2009.
- J. S. Popova and M. M. Rasenick, “Gβγ mediates the interplay between tubulin dimmers and microtubules in the modulation of Gq signaling,” Journal of Biological Chemistry, vol. 278, no. 36, pp. 34299–34308, 2003.
- J. Gao, L. Huo, X. Sun et al., “The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration,” Journal of Biological Chemistry, vol. 283, no. 14, pp. 8802–8809, 2008.
- A. D. Bicek, E. Tüzel, A. Demtchouk et al., “Anterograde microtubule transport drives microtubule bending in LLC-PK1 epithelial cells,” Molecular Biology of the Cell, vol. 20, no. 12, pp. 2943–2953, 2009.
- M. Bilban, A. Haschemi, B. Wegiel, B. Y. Chin, O. Wagner, and L. E. Otterbein, “Heme oxygenase and carbon monoxide initiate homeostatic signaling,” Journal of Molecular Medicine, vol. 86, no. 3, pp. 267–279, 2008.
- V. L. Gabai and M. Y. Sherman, “Invited review: interplay between molecular chaperones and signaling pathways in survival of heat shock,” Journal of Applied Physiology, vol. 92, no. 4, pp. 1743–1748, 2002.
- K. D. Singleton, V. E. Beckey, and P. E. Wischmeyer, “Glutamine prevents activations of NF-κB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis,” Shock, vol. 24, no. 6, pp. 583–589, 2005.
- K. D. Singleton and P. E. Wischmeyer, “Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression,” American Journal of Physiology, vol. 292, no. 5, pp. R1839–R1845, 2007.